UroToday

Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: Clinical outcomes - Abstract

Published on Thursday, 23 May 2013 09:36

OBJECTIVES: To evaluate biochemical non-evidence of disease and adverse events of salvage intensity-modulated radiotherapy using an endorectal balloon for prostate cancer patients after radical prostatectomy.

BJUI Mini Reviews - Current role of diethylstilbestrol in the management of advanced prostate cancer

Published on Thursday, 23 May 2013 00:00

BERKELEY, CA (UroToday.com) - The aim of this review was to describe the most recent data from contemporary clinical trials of diethylstilbestrol ( DES) to better determine its current role in advanced prostate cancer treatment as new hormonal therapies emerge.

Response to the U.S. Preventative Services Task Force decision on prostate cancer screening - Abstract

Published on Wednesday, 22 May 2013 09:31

The population-level data demonstrate that the inception of prostate-specific antigen (PSA) screening has lowered mortality for prostate cancer over the past 2 decades.

MRI-guided biopsy for prostate cancer detection: A systematic review of current clinical results - Abstract

Published on Wednesday, 22 May 2013 09:27

In-bore magnetic resonance-guided biopsy (MRGB) has been increasingly used in clinical practice to detect prostate cancer (PCa).

Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer - Abstract

Published on Wednesday, 22 May 2013 09:18

OBJECTIVE: To determine the effectiveness and toxicity of docetaxel for Chinese patients with castrate-resistant prostate cancer in a local Hong Kong hospital.

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer - Abstract

Published on Wednesday, 22 May 2013 09:11

PURPOSE: To analyze the baseline clinicopathologic characteristics of prostate tumors with germline BRCA1 and BRCA2 (BRCA1/2) mutations and the prognostic value of those mutations on prostate cancer (PCa) outcomes.

Impact of age at diagnosis on outcomes in men with castrate-resistant prostate cancer (CRPC) - Abstract

Published on Wednesday, 22 May 2013 07:42

Background: The association between age and outcomes in men with castrate resistant prostate cancer (CRPC) is not well understood.

Prognostic significance of patterns of seminal vesicle invasion in prostate cancer - Abstract

Published on Wednesday, 22 May 2013 07:36

AIMS: We aimed to evaluate the prognostic significance of histopathological patterns of seminal vesicle invasion (SVI) after radical prostatectomy.

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: Early results - Abstract

Published on Wednesday, 22 May 2013 07:31

BACKGROUND: There is growing evidence that prostate cancer (PC) cells are more sensitive to high fraction dose in hypofractionation schemes.

New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication - Abstract

Published on Wednesday, 22 May 2013 07:26

Obesity and type 2 diabetes are recognised risk factors for the development of some cancers and, increasingly, predict more aggressive disease, treatment failure, and cancer-specific mortality.

Page 2 of 1755